Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
1,1-Cyclobutane Dicarboxylic Acid
CAS Number : 5445-51-2
End Use API : Carboplatin
About The Company : MINAKEM is a cGMP custom manufacturer specializing in small molecule APIs, HPAPIs, and steroids. Its highly skilled R&D teams, supported by strong analytical an...
Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.
Diethyl-1,1-Cyclobutane Dicarboxylate
CAS Number : 3779-29-1
End Use API : Carboplatin
About The Company : MINAKEM is a cGMP custom manufacturer specializing in small molecule APIs, HPAPIs, and steroids. Its highly skilled R&D teams, supported by strong analytical an...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Chewable & Orodispersible Aids
Taste Masking
Direct Compression
Disintegrants & Superdisintegrants
Parenteral
Co-Processed Excipients
Granulation
Solubilizers
Thickeners and Stabilizers
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
88
PharmaCompass offers a list of Carboplatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Carboplatin manufacturer or Carboplatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Carboplatin manufacturer or Carboplatin supplier.
A Carbosin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Carbosin, including repackagers and relabelers. The FDA regulates Carbosin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Carbosin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Carbosin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Carbosin supplier is an individual or a company that provides Carbosin active pharmaceutical ingredient (API) or Carbosin finished formulations upon request. The Carbosin suppliers may include Carbosin API manufacturers, exporters, distributors and traders.
click here to find a list of Carbosin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Carbosin DMF (Drug Master File) is a document detailing the whole manufacturing process of Carbosin active pharmaceutical ingredient (API) in detail. Different forms of Carbosin DMFs exist exist since differing nations have different regulations, such as Carbosin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Carbosin DMF submitted to regulatory agencies in the US is known as a USDMF. Carbosin USDMF includes data on Carbosin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Carbosin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Carbosin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Carbosin Drug Master File in Japan (Carbosin JDMF) empowers Carbosin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Carbosin JDMF during the approval evaluation for pharmaceutical products. At the time of Carbosin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Carbosin suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Carbosin Drug Master File in Korea (Carbosin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Carbosin. The MFDS reviews the Carbosin KDMF as part of the drug registration process and uses the information provided in the Carbosin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Carbosin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Carbosin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Carbosin suppliers with KDMF on PharmaCompass.
A Carbosin CEP of the European Pharmacopoeia monograph is often referred to as a Carbosin Certificate of Suitability (COS). The purpose of a Carbosin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Carbosin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Carbosin to their clients by showing that a Carbosin CEP has been issued for it. The manufacturer submits a Carbosin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Carbosin CEP holder for the record. Additionally, the data presented in the Carbosin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Carbosin DMF.
A Carbosin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Carbosin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Carbosin suppliers with CEP (COS) on PharmaCompass.
A Carbosin written confirmation (Carbosin WC) is an official document issued by a regulatory agency to a Carbosin manufacturer, verifying that the manufacturing facility of a Carbosin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Carbosin APIs or Carbosin finished pharmaceutical products to another nation, regulatory agencies frequently require a Carbosin WC (written confirmation) as part of the regulatory process.
click here to find a list of Carbosin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Carbosin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Carbosin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Carbosin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Carbosin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Carbosin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Carbosin suppliers with NDC on PharmaCompass.
Carbosin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Carbosin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Carbosin GMP manufacturer or Carbosin GMP API supplier for your needs.
A Carbosin CoA (Certificate of Analysis) is a formal document that attests to Carbosin's compliance with Carbosin specifications and serves as a tool for batch-level quality control.
Carbosin CoA mostly includes findings from lab analyses of a specific batch. For each Carbosin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Carbosin may be tested according to a variety of international standards, such as European Pharmacopoeia (Carbosin EP), Carbosin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Carbosin USP).
